Trials / Completed
CompletedNCT03110679
Randomized Double-blind Study on the Treatment of Osteoarthritis of the Bilateral Knee: Autologous Bone Marrow Concentrate vs. Hyaluronic Acid
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 60 (actual)
- Sponsor
- Istituto Ortopedico Rizzoli · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Accepted
Summary
OA-bi-Blind is a randomized double-blind study on the treatment of osteoarthritis of the Bilateral knee: autologous bone marrow concentrate vs. hyaluronic acid.
Detailed description
a randomized, controlled, double-blind study and we will be evaluated and compared the clinical and radiological results of concentrated autologous bone marrow against the hyaluronic acid in patients with bilateral knee osteoarthrosis . In randomization, one knee will be treated with autologous bone marrow concentrate and other knee with hyaluronic acid, then every patient is considered both in control and treatment group, limiting the heterogenity between groups and will not be informed of the knee assigned to the treatment group.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | injection of autologous bone marrow concentrate | |
| BIOLOGICAL | injection of hyaluronic acid. |
Timeline
- Start date
- 2016-05-23
- Primary completion
- 2016-11-01
- Completion
- 2021-05-01
- First posted
- 2017-04-12
- Last updated
- 2021-08-04
Locations
1 site across 1 country: Italy
Source: ClinicalTrials.gov record NCT03110679. Inclusion in this directory is not an endorsement.